Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-08-22FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly. The approval covers changes under a supplemental submi…
-
FDA approval · 2007-08-22FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company to update the product's lab…
-
FDA approval · 2007-08-14FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2007-06-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2007-06-13FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for Metformin hydrochloride (generic) from Mylan Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-05-16FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2007-04-25FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2007-04-10FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUVIA (sitagliptin) from Merck Sharp & Dohme LLC.
-
FDA approval · 2007-03-30FDA Approved: JANUMET — Original Application (Merck Sharp & Dohme LLC)
FDA approved JANUMET (sitagliptin and metformin hydrochloride) through an original application filed by Merck Sharp & Dohme LLC.
-
FDA approval · 2007-03-16FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METFORMIN HYDROCHLORIDE from Aurobindo Pharma Limited. This action approves a generic metformin …
-
FDA approval · 2007-02-25FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2007-02-15FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for metformin hydrochloride from Amneal Pharmaceuticals of New York LLC, granting regulatory app…
-
FDA approval · 2007-02-06FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a pioglitazone and glimepiride fixed-dose combination from Prasco Laboratories.
-
FDA approval · 2006-12-22FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Byetta (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2006-11-04FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) from Takeda Pharmaceuticals America,…
-
FDA approval · 2006-11-01FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP. The action updates or expands th…
-
FDA approval · 2006-11-01FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA has approved a supplemental application for Metformin Hydrochloride from Oceanside Pharmaceuticals. The approval adds or changes to …
-
FDA approval · 2006-10-27FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk.
-
FDA approval · 2006-10-16FDA Approved: JANUVIA — Original Application (Merck Sharp & Dohme LLC)
FDA approves JANUVIA (sitagliptin) under the original application from Merck Sharp & Dohme LLC for the treatment of type 2 diabetes mellitus…
-
FDA approval · 2006-10-12FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP. This action updates the appr…
-
FDA approval · 2006-09-28FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met, a fixed-dose combination of pioglitazone and metformin hydrochloride. The product …
-
FDA approval · 2006-09-28FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approves a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2006-08-30FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met (pioglitazone and metformin hydrochloride) submitted by Takeda Pharmaceuticals Amer…
-
FDA approval · 2006-08-30FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2006-08-15FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approval of a supplemental application for a generic bromocriptine mesylate product by Mylan Pharmaceuticals Inc.